ELNUGA - Company finances
|
EUR
|
2023
From: 2023-05-02
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 125,852 | 258,817 | 270,273 |
| Profit before tax | 42,375 | 54,392 | 10,696 |
| Net profit | 40,238 | 51,675 | 10,089 |
| Equity | 42,738 | 54,175 | 28,970 |
| Liabilities | 15,993 | 17,018 | 28,322 |
| Non-current assets | 0 | 0 | 0 |
| Current assets | 59,214 | 71,193 | 57,292 |
| Total assets | 59,214 | 71,193 | 57,292 |
|
Taxes paid
|
|||
| STI taxes | 8,833 | 38,447 | 33,663 |
| Social insurance contributions | 4,898 | 14,533 | 9,606 |
|
Financial indicators
|
|||
| Revenue change y/y | - | +105.7% | +4.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 68.0% | 72.6% | 17.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 94.2% | 95.4% | 34.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 32.0% | 20.0% | 3.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 33.7% | 21.0% | 4.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.4 | 0.3 | 1.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 35,958 | 56,470 | 58,969 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
ELNUGA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-10-23 | 2025-11-04 | 0.09 |
| 2025-07-16 | 2025-08-05 | 15.61 |
ELNUGA - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company ELNUGA is: 2 €
| From | To | Overdue, € |
|---|---|---|
| 2026-08-31 | 2026-09-02 | 1.94 |
| 2026-08-28 | 2026-08-30 | 2.0 |
| 2026-08-18 | 2026-08-23 | 212.34 |
| 2026-08-17 | 2026-08-17 | 149.17 |
| 2026-08-07 | 2026-08-16 | 148.81 |
| 2026-08-02 | 2026-08-06 | 148.57 |
| 2026-07-02 | 2026-07-07 | 28.29 |
| 2026-06-28 | 2026-07-01 | 28.24 |
| 2026-01-11 | 2026-01-24 | 0.68 |
| 2025-09-28 | 2025-10-22 | 7.09 |
| 2025-08-28 | 2025-09-25 | 7.09 |
| 2025-07-28 | 2025-08-19 | 7.09 |
| 2025-06-28 | 2025-07-22 | 7.09 |
| 2025-06-19 | 2025-06-25 | 7.09 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
ELNUGA, UAB (code 306309316) is a Private Limited Liability Company active in retail sale of other medical and orthopaedic goods. In 2025, the company generated revenue of €270.3K, up 4.4% year on year and 114.8% over two years, while net profit declined to €10.1K from €51.7K in 2024 and €40.2K in 2023. This pushed the net profit margin down to 3.7% in 2025, compared with 20.0% in 2024 and 32.0% in 2023. The balance sheet remained relatively small: total assets were €57.3K, equity €29.0K and liabilities €28.3K at the end of 2025. Equity therefore represented 50.6% of assets, and debt to equity stood at 0.98. Asset turnover was 4.72x, indicating strong revenue generation relative to the asset base. Profitability ratios for 2025 were ROE of 34.8% and ROA of 17.6%. Revenue per employee was €67.6K, while profit per employee was €2.5K, showing that turnover grew faster than earnings in the latest year.